Research from Michigan suggests that use of statins and aspirin prior to percutaneous revascularization among patients with peripheral arterial disease, or PAD, appears to reduce the number of peripheral vascular events by more than half when measured at 6 months. The authors noted, however, that appropriate medical therapy—which also includes abstinence from smoking—was underutilized in this population.

Abstract: Circulation: Cardiovascular Interventions, December 11, 2012 (online).

Author